Home > News > Monster and BioValley.ch unite
November 27th, 2006
Monster and BioValley.ch unite
Abstract:
"In the greater Basel area alone, approximately 200 start-up companies have been established, many of them as spin-offs from the pharmaceutical industry, or from academic research institutions such as the Biocenter http://www.biozentrum.unibas.ch/ of the University of Basel http://www.unibas.ch, the Friedrich Miescher Institute (FMI) http://www.fmi.ch/ and the National Center of Competence in Research for Nanotechnology (NCCR) http://www.nanovip.com/directory/Detailed/1365.php," highlighted Peter Raeber, who is a Business Development Manager for BaselArea http://www.baselarea.org/intro.html. "This trend is increasing and will create new business opportunities, especially for venture capitalists."
Source:
checkbiotech.org
Related News Press |
Jobs
Could quantum technology be New Mexico’s next economic boon? Quantum New Mexico Coalition aims to establish state as national hub April 1st, 2022
SEMI Partners with GLOBALFOUNDRIES to Offer Apprenticeship Program Aimed at Building the Electronics Talent Pipeline August 11th, 2020
Arrowhead Pharmaceuticals Reports Inducement Grants under NASDAQ Marketplace Rule 5635(c)(4) March 29th, 2019
Announcements
Nanotechnology: Flexible biosensors with modular design November 8th, 2024
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Turning up the signal November 8th, 2024
Nanofibrous metal oxide semiconductor for sensory face November 8th, 2024
The latest news from around the world, FREE | ||
Premium Products | ||
Only the news you want to read!
Learn More |
||
Full-service, expert consulting
Learn More |
||